Evaluation of the effectiveness of risk minimization measures for trimetazidine: A cross sectional joint PASS survey among physicians in selected European countries.
- DOI
- 10.1002/pds.4675
- Published
- 2018-10-31
- Container
- Pharmacoepidemiol Drug Saf
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/pds.4675,
title = {Evaluation of the effectiveness of risk minimization measures for trimetazidine: A cross sectional joint PASS survey among physicians in selected European countries.},
author = {von Bredow D and Toussi M and Samad A and Kaplan S and Domahidy M and de Voogd H and Böhmert S and Ramos RS and Arora D.},
year = {2018},
journal = {Pharmacoepidemiol Drug Saf},
doi = {10.1002/pds.4675},
url = {https://doi.org/10.1002/pds.4675}
}RIS
TY - JOUR TI - Evaluation of the effectiveness of risk minimization measures for trimetazidine: A cross sectional joint PASS survey among physicians in selected European countries. AU - von Bredow D AU - Toussi M AU - Samad A AU - Kaplan S AU - Domahidy M AU - de Voogd H AU - Böhmert S AU - Ramos RS AU - Arora D. PY - 2018 JO - Pharmacoepidemiol Drug Saf DO - 10.1002/pds.4675 UR - https://doi.org/10.1002/pds.4675 ER -
APA
D, V. B., M, T., A, S., S, K., M, D., H, D. V., S, B., RS, R., & D., A. (2018). Evaluation of the effectiveness of risk minimization measures for trimetazidine: A cross sectional joint PASS survey among physicians in selected European countries.. Pharmacoepidemiol Drug Saf. https://doi.org/10.1002/pds.4675
Source records
- europe-pmc · retrieved 2026-09-24T23:43:16.802Z